Which biochemistry journal fits your draft?
Run the Free Readiness Scan with your draft to see fit, framing, and desk-reject risk for the biochemistry journal you are targeting.
Best Biochemistry Journals (2026): Ranked by Impact and Accessibility
Ranked list of the top 12 biochemistry journals by scope fit, selectivity, APC, and review speed, with guidance on placing protein, enzyme, nucleic acid, and chemical biology manuscripts.
Readiness scan
Which biochemistry journal fits your draft?
Run the Free Readiness Scan with your draft to see fit, framing, and desk-reject risk for the biochemistry journal you are targeting.
Quick answer: The best biochemistry journal is the one whose readers already care about your paper's protagonist. This guide ranks 12 journals across five lanes: mechanism, chemical biology, structure, nucleic acids and broad molecular biology. Impact factor is the tiebreaker, not the starting point.
Searching for one journal's impact factor? Watch the names first. "Biochemistry" (the ACS journal), the Journal of Biochemistry and the Biochemical Journal are three separate titles, and search results mix them up often enough that the number you find may belong to the wrong one. Match the ISSN on the publisher's page before you quote a figure. For the field's workhorse, see the Journal of Biological Chemistry impact factor page.
Evidence basis: Current society and publisher journal pages plus field-index records were reviewed on August 16, 2026. How this guide selects journals: each title had to publish biochemistry as a core lane, not an occasional topic, and each is placed by the kind of result its editors screen for. Metrics are time-stamped context; the scientific-protagonist routing table is Manusights editorial judgment and cannot predict acceptance or editorial priority. A stop signal is a paper whose biological, chemical, structural, or methodological protagonist changes from the abstract to the main evidence.
How this guide was built: the shortlist below covers distinct biochemistry sub-fields (mechanistic, structural, chemical-biology, nucleic-acid, and enzymology) rather than repeating the same scope five times, using each publisher's own scope page and current indexing status rather than a single generic ranking.
Compare each venue by the contribution it rewards and the evidence it expects.
When should you choose Molecular Cell?
Fit and evidence test
Molecular Cell is the top Cell Press journal for mechanistic molecular biology and biochemistry. The journal wants complete molecular stories: if you've characterized an enzyme, Molecular Cell expects the structure, the kinetics, the biological context, and the functional consequences. Papers here define how molecular machines work. The bar is high, but a Molecular Cell paper establishes you as a leader in your area.
When should you choose Nucleic Acids Research?
Fit and evidence test
NAR is the definitive journal for DNA and RNA biochemistry, gene regulation, and nucleic acid tools. The journal occupies a unique position with both a high-impact research section (~20% acceptance) and an annual web server/database issue (~40% acceptance). For any biochemistry involving nucleic acids, from CRISPR mechanisms to ribosome biochemistry to transcription factor characterization, NAR is the first target. The review process is fast and expert reviewers provide constructive feedback.
When should you choose Nature Chemical Biology?
Fit and evidence test
Nature Chemical Biology sits at the intersection of chemistry and biology, publishing papers that use chemical approaches to reveal biological mechanisms. If your biochemistry paper involves chemical probes, metabolite identification, or chemical tool development, this journal values the chemical perspective that pure biology journals might underweight. The current gold OA APC is $12,850, though institutional agreements may cover it; subscription publication remains an option for primary research.
When should you choose Nature Structural and Molecular Biology?
Fit and evidence test
NSMB is the top venue for structural biochemistry. If your paper's primary contribution is a cryo-EM structure, crystal structure, or NMR study that reveals how a biological machine works, NSMB is where structural biologists look first. The journal also publishes integrative structural studies combining multiple biophysical approaches.
When should you choose EMBO Journal?
Fit and evidence test
The European Molecular Biology Organization's flagship publishes mechanistic molecular biology with functional insight. EMBO Journal values European-style rigorous biochemistry: thorough kinetic characterization, careful controls, and functional validation. The transparent review process (referees see each other's reports) produces balanced feedback. A strong choice for molecular mechanisms of gene regulation, protein quality control, and membrane biochemistry.
When should you choose ACS Chemical Biology?
Fit and evidence test
The ACS journal for chemical biology research publishes at the chemistry-biology interface. If your paper uses chemical tools, synthetic probes, or chemical approaches to study biology, ACS Chemical Biology reaches chemists and biologists. It's more accessible than Nature Chemical Biology and values the chemical methodology alongside the biological insight.
When should you choose Journal of Biological Chemistry?
Fit and evidence test
JBC is the biochemistry workhorse. For over a century, it's been the journal where biochemists publish protein characterization, enzyme kinetics, post-translational modifications, and signaling pathway biochemistry. The acceptance rate (~40%) is the most accessible among respected biochemistry journals, and the journal publishes a high volume of papers. JBC won't make the same splash as Molecular Cell, but a JBC paper is a solid, respected contribution. Don't underestimate it: many highly cited papers in biochemistry are in JBC.
When should you choose Journal of Molecular Biology?
Fit and evidence test
JMB publishes structural and molecular biology with a long tradition dating to the origin of the field. The journal is strong for structural studies, protein-protein interactions, and molecular characterization. It's one of the few remaining subscription journals in the field with no APC, which matters for labs with limited publication budgets.
When should you choose Protein Science?
Fit and evidence test
For papers primarily about protein structure, folding, function, or engineering, Protein Science is the dedicated journal. Published by the Protein Society, it reaches every protein biochemist. If your paper is a thorough protein characterization that doesn't tell a broader biological story, Protein Science values the protein science contribution on its own merits.
When should you choose Biochemistry (ACS)?
Fit and evidence test
The ACS Biochemistry journal focuses on physical biochemistry: thermodynamics, kinetics, spectroscopy, and biophysical characterization. If your paper is quantitative biochemistry with physical chemistry depth, Biochemistry reaches researchers who appreciate that rigor. The acceptance rate (~35%) is reasonable.
When should you choose FEBS Journal?
Fit and evidence test
The Federation of European Biochemical Societies journal publishes broad biochemistry with a European editorial perspective. FEBS Journal is strong for enzyme characterization, metabolic biochemistry, and protein function studies. The journal also publishes themed special issues that can increase your paper's visibility.
When should you choose Biochemical Journal?
Fit and evidence test
Published by Portland Press (the Biochemical Society's publishing arm), Biochemical Journal covers all areas of biochemistry with particular strength in signal transduction, metabolic regulation, and enzyme function. The acceptance rate (~30%) makes it accessible for well-executed biochemistry studies.
Name the paper's scientific protagonist
Protagonist | Shortlist lane | The first result should establish |
|---|---|---|
Enzyme, pathway, or molecular mechanism | Biochemistry or molecular-biology journals | Causal biochemical insight, not only phenotype |
Chemical probe or molecular intervention | Chemical-biology journals | Selectivity, mechanism, and biological consequence |
Structure and dynamics | Structural or biophysical journals | What the structure explains or predicts |
Nucleic-acid biology or resource | Nucleic-acid journals | Community or mechanistic value beyond one dataset |
Broad cell-biological discovery | Cell and molecular-biology journals | Consequence beyond the biochemical system |
The best journal is usually the one whose readers recognize the protagonist without translating the paper into another discipline. Use the table before comparing metrics; it prevents a technically excellent biochemistry paper from being framed for the wrong editorial conversation.
That flexibility is both an advantage and a source of confusion.
Choosing the right journal means understanding whether your paper's strength is the mechanistic biology, the chemical insight, or the methodological innovation.
For biochemistry with biological insight, Molecular Cell (IF ~16) and EMBO Journal (IF ~8.7) are the top destinations. For chemical biology specifically, Nature Chemical Biology (IF ~15.8) leads. For protein biochemistry and enzymology, Journal of Biological Chemistry (IF ~4.1) remains the field's workhorse. For structural biochemistry, Nature Structural and Molecular Biology (IF ~10.1) is the best fit. For nucleic acid biochemistry, Nucleic Acids Research (IF ~15) is unmatched.
Before picking from the biochemistry journals below, run a biochemistry manuscript fit check to see whether your draft is closer to a top-tier or accessible-tier target before you commit to a submission.
The full biochemistry journal landscape
Journal | Impact Factor | Acceptance Rate | APC | Review Time | Best For |
|---|---|---|---|---|---|
Molecular Cell | ~16 | 11% | No APC | 4-8 weeks | Molecular mechanisms, Cell Press |
Nucleic Acids Research | ~15 | ~20% | $3,950 | 4-8 weeks | DNA/RNA biochemistry, tools |
Nature Chemical Biology | 15.8 | Not publicly disclosed | $12,850 | 11 days to first editorial decision | Chemical biology interface |
NSMB | ~10.1 | ~12% | $11,690 | 4-8 weeks | Structural biochemistry |
EMBO Journal | ~8.7 | ~12% | $5,460 | 6-10 weeks | Molecular biology, European |
ACS Chemical Biology | ~3.6 | ~25% | $3,000 | 4-8 weeks | Chemical biology, ACS |
Journal of Biological Chemistry | ~4.1 | 38% | $3,430 | 4-8 weeks | Protein/enzyme biochemistry |
Biochemistry (ACS) | ~3 | ~35% | $3,000 | 4-8 weeks | Physical biochemistry |
FEBS Journal | ~4.2 | ~30% | $3,200 | 6-10 weeks | European biochemistry |
Biochemical Journal | ~4.3 | ~30% | $3,330 | 6-10 weeks | Broad biochemistry |
Journal of Molecular Biology | ~4.7 | ~25% | No APC | 6-10 weeks | Structural/molecular biology |
Protein Science | ~5.6 | ~35% | $2,500 | 6-8 weeks | Protein structure/function |
Publisher-reported acceptance figures link to their source. Elsevier catalog figures were checked in October 2026; the catalog does not specify the reporting period or submission denominator.
How to evaluate the shortlist
If the paper's main claim is physical rather than chemical (mechanics, energetics, transport, imaging, instrumentation, or a quantitative model-to-data test), use the biophysics journal fit guide before choosing a biochemistry venue.
If your paper reveals a molecular mechanism with biological significance: Molecular Cell first, then EMBO Journal. Both want the mechanism and the biological context.
If your paper is structural biochemistry: NSMB for the highest impact, then JMB or Protein Science for focused structural studies.
If your paper involves chemical biology or chemical tools: Nature Chemical Biology (highest bar), then ACS Chemical Biology (more accessible).
If your paper is DNA/RNA biochemistry: NAR is the clear first choice, regardless of the specific sub-topic.
If your paper is protein characterization or enzymology: JBC for established proteins with new functional insight, Protein Science for focused protein studies, Biochemistry for quantitative biophysical characterization.
If your paper is metabolic biochemistry: Cell Metabolism (if the biological implications are broad), JBC (for the biochemical characterization), or FEBS Journal.
If your project is a field-shaping review rather than primary research: start with the Annual Review of Biochemistry submission guide to decide whether the invitation path, synthesis thesis, and author authority fit before drafting.
Readiness check
Find out what this manuscript actually needs before you choose a service.
Run the free scan to see whether the issue is scientific readiness, journal fit, or citation support before paying for more help.
Common biochemistry journal-fit failure patterns
Confusing biochemistry with cell biology. If your paper's primary experiments are cell-based (imaging, flow cytometry, phenotypic assays), it's cell biology, not biochemistry. Target Cell Reports or Journal of Cell Biology instead of JBC or Biochemistry.
Defaulting to a low-impact journal when your data supports a higher one. Many biochemists have strong data but undersell their work. If your enzyme characterization reveals a new regulatory mechanism with biological implications, that's not just a JBC paper. It could be EMBO Journal or Molecular Cell with the right framing.
Ignoring NAR for nucleic acid work. Researchers sometimes submit DNA/RNA biochemistry to general biochemistry journals when NAR would provide a larger, more expert readership with a comparable or higher JIF.
Treating JBC as a "low-tier" journal. JBC's IF (~3.9) is lower than Molecular Cell or EMBO Journal, but it's the most-read biochemistry journal by volume, and its papers are frequently cited. A solid JBC paper establishes your work in the field's primary literature.
A kinetics table standing in for a mechanism. A panel of Michaelis-Menten parameters for eight point mutants tells an editor what changed, not why. With no structure, no transition-state argument and no in-cell consequence, that paper belongs at JBC or Biochemistry (ACS), however clean the assays are. Pitch it to Molecular Cell and the first question back will be "so what does the cell do differently?"
A structure with nothing tested against it. Structural journals want to know what the model explains or predicts. A cryo-EM map at good resolution whose only validation is the map itself reads as a deposition, not a paper. One mutation designed from the structure, with the predicted functional effect, is usually the difference between an NSMB conversation and a Protein Science one.
A chemical probe without its selectivity data. Chemical-biology editors read the selectivity panel before the biology. If the off-target profiling is promised for a follow-up, the paper is not ready for Nature Chemical Biology or ACS Chemical Biology yet.
Final target decision
Run your manuscript through a manuscript readiness and scope check to check scope alignment, formatting, and structural completeness for your target biochemistry journal.
Biochemistry journal-fit selection checklist
- Match scope precisely. A biochemistry paper on clinical outcomes fits different journals than one on mechanisms.
- Check your constraints. Funder OA mandates, APC budgets, and timeline requirements narrow the list.
- Prioritize your audience. The best journal is where your citing researchers actually read.
- Be realistic about selectivity. If acceptance is <10%, have a backup identified.
Frequently asked questions
Nature Chemical Biology (IF ~15.8), Molecular Cell (IF ~16), and EMBO Journal (IF ~8.7) are the top journals publishing biochemistry. For pure enzymology and protein biochemistry, Journal of Biological Chemistry (IF ~4.1) remains the field workhorse with the broadest scope.
In biochemistry, an IF above 10 is elite (Nature Chemical Biology, Molecular Cell), 5-10 is strong (EMBO Journal, ACS Chemical Biology), 3-5 is solid (JBC, Biochemistry, FEBS Journal), and below 3 is accessible. The field has lower average IFs than clinical medicine but strong journals carry real weight.
Yes. eLife publishes excellent biochemistry with transparent review. PLOS Biology is strong for biochemistry with broad implications. Frontiers in Molecular Biosciences and BMC Biochemistry are accessible OA options. NAR is the go-to for nucleic acid biochemistry.
Sources
Free guide
A ranked list cannot tell you where your own paper belongs.
The guide runs the last-ten-papers test, which is reading what a journal has actually published recently and asking whether your paper would sit comfortably beside it. Then you score each candidate 0 to 2 on fit, and let impact factor break ties rather than start the decision.
Final step
Run the scan before you spend more on editing or external review.
Use the Free Readiness Scan to get a manuscript-specific signal on readiness, fit, figures, and citation risk before choosing the next paid service.
Best for commercial comparison pages where the buyer is still choosing the right help.
Private API processing. Your manuscript is not used to train models.
See example reportsPut the guidance to work
Build a journal decision from more than one signal.
Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.